Inventor

BEN-NERIAH YINON

IL14 patents

⚠️ This page may combine multiple inventors who share the name “BEN-NERIAH YINON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD

7 patents

US10376511B2Aug 13, 2019

Heteroaryl compounds, pharmaceutical compositions thereof, and their therapeutic use

YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD0 citations61

US11999721B2Jun 4, 2024

Pyrazole compounds and uses thereof

YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD0 citations59

US11925641B2Mar 12, 2024

Pyrazole pyrimidine derivative and uses thereof

YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD0 citations59

US12514859B2Jan 6, 2026

Pyrazole pyrimidine derivative and uses thereof

YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD0 citations57

SIGNAL PHARM INC

2 patents

US5932425AAug 3, 1999

Compositions and methods for modulating cellular NF-κB activation

SIGNAL PHARM INC35 citations90

US6656713B2Dec 2, 2003

Compounds and methods for modulating activation of NF-κB

SIGNAL PHARM INC14 citations89

SIGNAL PHARM LLC

1 patent

US7186503B2Mar 6, 2007

Compounds and methods for modulating activation of NF-κB

SIGNAL PHARM LLC2 citations59

SIGNAL PHARMACEUTICALS

1 patent

US7414120B2Aug 19, 2008

Compounds and methods for modulating activation of NF-κB

SIGNAL PHARMACEUTICALS2 citations58

YISSUM RES DEV CO

1 patent

US6905836B2Jun 14, 2005

Methods for identifying compounds that inhibit ubiquitin-mediated proteolysis of iκb

YISSUM RES DEV CO0 citations44

MANNING ANTHONY M

1 patent

US8263326B2Sep 11, 2012

Compounds and methods for modulating activation of NF-κB

MANNING ANTHONY M0 citations42

BEN-NERIAH YINON

1 patent

US9623109B2Apr 18, 2017

Methods of killing cells and use of same in prevention and treatment of cancer

BEN-NERIAH YINON0 citations32